Greg Renza

Stock Analyst at RBC Capital

(2.80)
# 1,840
Out of 4,947 analysts
1
Total ratings
100%
Success rate
31.14%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Greg Renza

BeOne Medicines
Apr 7, 2025
Initiates: Outperform
Price Target: $312
Current: $309.69
Upside: +0.75%